StockMarketWire.com - Peel Hunt today reaffirms its buy investment rating on Shield Therapeutics Plc [LON:STX] and raised its price target to 88p (from 70p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk